N2off, INC DEF 14A proxy statements

Nexentis Technologies Inc. calls a special meeting to approve a reverse stock split, a discounted equity issuance, and an expanded credit facility to maintain Nasdaq listing and fund operations.

N2OFF, Inc. announced its annual stockholder meeting to vote on director elections, a significant increase in its share incentive plan, and an advisory vote on director share grants.

N2OFF, Inc. calls a special meeting to approve the acquisition of cancer drug discovery firm MitoCareX Bio Ltd., a significant stock issuance, and a reverse stock split to maintain Nasdaq listing.

N2OFF, Inc. amended its bylaws to lower the quorum requirement for stockholder meetings to one-third ahead of its Annual Meeting on November 13, 2024.

N2OFF, Inc. is holding its annual meeting of stockholders on November 13, 2024, to vote on key proposals including the election of directors, an amendment to the share incentive plan, an increase in authorized capital, and the potential issuance of securities in non-public offerings.

N2OFF, Inc. is holding a special meeting of stockholders to vote on proposals for a reverse stock split and an increase in the number of authorized shares to maintain Nasdaq listing compliance and facilitate future financing.